Logo image of HLP

HONGLI GROUP INC (HLP) Stock Fundamental Analysis

NASDAQ:HLP - Nasdaq - KYG4594M1087 - Common Stock - Currency: USD

0.99  +0.04 (+4.21%)

Fundamental Rating

2

Overall HLP gets a fundamental rating of 2 out of 10. We evaluated HLP against 153 industry peers in the Metals & Mining industry. While HLP seems to be doing ok healthwise, there are quite some concerns on its profitability. HLP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year HLP has reported negative net income.
HLP had a positive operating cash flow in the past year.
HLP had positive earnings in each of the past 5 years.
Each year in the past 5 years HLP had a positive operating cash flow.
HLP Yearly Net Income VS EBIT VS OCF VS FCFHLP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 2M -2M -4M -6M

1.2 Ratios

HLP has a Return On Assets of -3.17%. This is comparable to the rest of the industry: HLP outperforms 43.79% of its industry peers.
HLP's Return On Equity of -5.02% is in line compared to the rest of the industry. HLP outperforms 43.79% of its industry peers.
Industry RankSector Rank
ROA -3.17%
ROE -5.02%
ROIC N/A
ROA(3y)8.48%
ROA(5y)12.85%
ROE(3y)17.9%
ROE(5y)24.84%
ROIC(3y)N/A
ROIC(5y)N/A
HLP Yearly ROA, ROE, ROICHLP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 10 20 30 40

1.3 Margins

HLP's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of HLP has declined.
HLP's Gross Margin of 32.88% is fine compared to the rest of the industry. HLP outperforms 71.90% of its industry peers.
HLP's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for HLP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 32.88%
OM growth 3Y-33.95%
OM growth 5YN/A
PM growth 3Y-37.07%
PM growth 5YN/A
GM growth 3Y-6.31%
GM growth 5YN/A
HLP Yearly Profit, Operating, Gross MarginsHLP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 10 20 30 40

More info and screens

4

2. Health

2.1 Basic Checks

HLP does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, HLP has more shares outstanding
HLP has a better debt/assets ratio than last year.
HLP Yearly Shares OutstandingHLP Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
HLP Yearly Total Debt VS Total AssetsHLP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

An Altman-Z score of 4.77 indicates that HLP is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 4.77, HLP is doing good in the industry, outperforming 75.16% of the companies in the same industry.
A Debt/Equity ratio of 0.18 indicates that HLP is not too dependend on debt financing.
HLP has a Debt to Equity ratio (0.18) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z 4.77
ROIC/WACCN/A
WACC8.46%
HLP Yearly LT Debt VS Equity VS FCFHLP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 5M -5M 10M 15M 20M

2.3 Liquidity

HLP has a Current Ratio of 1.44. This is a normal value and indicates that HLP is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.44, HLP is not doing good in the industry: 73.20% of the companies in the same industry are doing better.
HLP has a Quick Ratio of 1.16. This is a normal value and indicates that HLP is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of HLP (1.16) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 1.16
HLP Yearly Current Assets VS Current LiabilitesHLP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 5M 10M

More info and screens

1

3. Growth

3.1 Past

HLP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -124.58%.
HLP shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -28.34% yearly.
Looking at the last year, HLP shows a very negative growth in Revenue. The Revenue has decreased by -21.36% in the last year.
The Revenue has been growing by 12.75% on average over the past years. This is quite good.
EPS 1Y (TTM)-124.58%
EPS 3Y-28.34%
EPS 5YN/A
EPS Q2Q%-311.34%
Revenue 1Y (TTM)-21.36%
Revenue growth 3Y12.75%
Revenue growth 5YN/A
Sales Q2Q%-21.91%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HLP Yearly Revenue VS EstimatesHLP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

HLP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HLP Price Earnings VS Forward Price EarningsHLP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

HLP's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 364.82
HLP Per share dataHLP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

HLP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HONGLI GROUP INC

NASDAQ:HLP (5/29/2025, 8:00:01 PM)

0.99

+0.04 (+4.21%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.05%
Inst Owner ChangeN/A
Ins Owners16.34%
Ins Owner ChangeN/A
Market Cap72.71M
AnalystsN/A
Price TargetN/A
Short Float %0.01%
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.17
P/FCF N/A
P/OCF 102.6
P/B 3.51
P/tB 4.49
EV/EBITDA 364.82
EPS(TTM)-0.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0.01
OCFY0.97%
SpS0.31
BVpS0.28
TBVpS0.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.17%
ROE -5.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 32.88%
FCFM N/A
ROA(3y)8.48%
ROA(5y)12.85%
ROE(3y)17.9%
ROE(5y)24.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)16.3%
ROCE(5y)26.87%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-33.95%
OM growth 5YN/A
PM growth 3Y-37.07%
PM growth 5YN/A
GM growth 3Y-6.31%
GM growth 5YN/A
F-Score3
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA 16.96
Cap/Depr 89.81%
Cap/Sales 3.48%
Interest Coverage N/A
Cash Conversion 326.69%
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 1.16
Altman-Z 4.77
F-Score3
WACC8.46%
ROIC/WACCN/A
Cap/Depr(3y)573.59%
Cap/Depr(5y)405.88%
Cap/Sales(3y)19%
Cap/Sales(5y)15.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-124.58%
EPS 3Y-28.34%
EPS 5YN/A
EPS Q2Q%-311.34%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-21.36%
Revenue growth 3Y12.75%
Revenue growth 5YN/A
Sales Q2Q%-21.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-118.18%
EBIT growth 3Y-25.52%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-105.67%
FCF growth 3Y-78.69%
FCF growth 5YN/A
OCF growth 1Y-78.53%
OCF growth 3Y-31.56%
OCF growth 5YN/A